Apply to trial NCT06667063

A few quick questions so the study team can decide if you might be a fit.

RecruitingClinical trial

Clinical Study on the Immune Response Characteristics of Novel Coronavirus and Influenza Virus Infection

This is an open-label, prospective observational study in people 18 years of age and older designed to track changes in the dynamics of the respiratory and peripheral blood immune response in people infected with influenza virus and new coronaviruses, and to resolve the characteristics of the virus-induced natural immune response.

How this works

Answer a few questions
About 5 to 10 minutes. Skip-friendly where possible.
We connect you with the study team
When a site picks up your application, we introduce you to their team directly — with you on the thread.
The team reaches out to schedule screening
Usually within a few business days, via the contact you give.

EmailWe save your progress under this email and copy you when we connect you with the study team.

I agree that Hipa.ai may share my application — my name, contact details, and my answers, including health information — with the official study team for this trial so they can review my responses and contact me.

By continuing, you agree to our terms of service.

Clinical Study on the Immune Response Characteristics of Novel Coronavirus and Influenza Virus Infection

How this works

Answer a few questions

We connect you with the study team

The team reaches out to schedule screening